Skadden Arps Slate Meagher & Flom, Freshfields Bruckhaus Deringer and Davis Polk are advising on US drugs giant Pfizer's bid to acquire UK rival AstraZeneca
April 28, 2014 at 10:58 AM
1 minute read
The original version of this story was published on Legalweek
Skadden Arps Slate Meagher & Flom, Freshfields Bruckhaus Deringer and Davis Polk are advising on US drugs giant Pfizer’s bid to acquire UK rival AstraZeneca.
Pfizer’s offer of around £60bn follows a rejected bid from the US company in January. It is thought any potential takeover could turn hostile after AstraZeneca released a statement today saying it felt it “was not appropriate to engage in discussions with Pfizer”.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
